Boston Scientific Corporation (BSX)
Automate Your Wheel Strategy on BSX
With Tiblio's Option Bot, you can configure your own wheel strategy including BSX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BSX
- Rev/Share 12.5086
- Book/Share 15.3216
- PB 6.545
- Debt/Equity 0.5365
- CurrentRatio 1.3721
- ROIC 0.0701
- MktCap 147049032158.0
- FreeCF/Share 2.2394
- PFCF 44.4123
- PE 58.6436
- Debt/Assets 0.2894
- DivYield 0
- ROE 0.1149
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | BSX | Erste Group | Buy | Hold | -- | -- | Oct. 3, 2025 |
| Upgrade | BSX | Oppenheimer | Perform | Outperform | -- | $125 | Sept. 8, 2025 |
| Initiation | BSX | Leerink Partners | -- | Outperform | -- | $118 | June 16, 2025 |
| Upgrade | BSX | Needham | Hold | Buy | -- | $113 | April 16, 2025 |
| Upgrade | BSX | Deutsche Bank | Hold | Buy | -- | $108 | Jan. 10, 2025 |
| Downgrade | BSX | Needham | Buy | Hold | -- | -- | Oct. 18, 2024 |
News
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Published: October 20, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how Boston Scientific (BSX) and Amarin (AMRN) have performed compared to their sector so far this year.
Read More
Unlocking Q3 Potential of Boston Scientific (BSX): Exploring Wall Street Estimates for Key Metrics
Published: October 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Read More
Will Robust Cardiovascular Performance Fuel BSX's Q3 Earnings?
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific's strong cardiovascular and MedSurg momentum, powered by innovations like WATCHMAN FLX Pro and AGENT DCB, could drive solid Q3 results.
Read More
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth
Published: October 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: October 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Medical technology stock picks for a ‘cautious' Q3: analysts
Published: October 07, 2025 by: Proactive Investors
Sentiment: Neutral
Citi analysts stressed being ‘cautious' on US medical technology stocks entering the third quarter, as the sector tends to underperform in September and October before recovering in November. In a note to clients on Tuesday, the analysts wrote that the sector was hit particularly hard this year as investors rotated out of healthcare and into technology.
Read More
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX)
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific (BSX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Read More
Healthcare equipment stocks seen outperforming, ‘safer' than Big Pharma: analysts
Published: September 30, 2025 by: Proactive Investors
Sentiment: Positive
UBS analysts are ‘Overweight' the healthcare equipment sector, with a Number One ranking on their total scorecard. In a note to clients on Tuesday, the analysts wrote that healthcare equipment has had the highest growth rate historically, excluding technology, at a 9% compound annual growth rate (CAGR) and the sector's earnings per share are now trading 10% below trend.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Is it a Prudent Move to Retain BSX Stock in Your Portfolio for Now?
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Neutral
Boston Scientific's acquisitions and WATCHMAN growth fuel optimism, but currency swings and macro pressures weigh on its outlook.
Read More
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
Published: September 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Boston Scientific (BSX) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.
Read More
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how Boston Scientific (BSX) and Allarity Therapeutics, Inc. (ALLR) have performed compared to their sector so far this year.
Read More
8 Growth Stocks to Buy That Aren't Technology. What Makes Them Worth It.
Published: August 25, 2025 by: Barrons
Sentiment: Positive
As tech stocks float at historic highs, it's a good time to look elsewhere for growth. A Citi screen turned up eight names that are mostly outside the tech sector.
Read More
HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.
Read More
Should Boston Scientific Stock Be in Your Portfolio Right Now?
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Positive
BSX's global expansion and MedSurg growth boost Q2 momentum, though currency and macro headwinds weigh on the same.
Read More
4 Medical Devices Behemoths to Buy Amid Extensive AI Applications
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Positive
AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Read More
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read More
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how Boston Scientific (BSX) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.
Read More
3 Reasons Growth Investors Will Love Boston Scientific (BSX)
Published: August 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Investors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to Know
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching Boston Scientific (BSX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
GEHC vs. BSX: Which Stock Is the Better Value Option?
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Read More
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
BSX beats Q2 estimates, raises full-year outlook as Cardiovascular sales surge and global revenues climb 22.8%.
Read More
Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript
Published: July 23, 2025 by: Seeking Alpha
Sentiment: Neutral
Boston Scientific Corporation (NYSE:BSX ) Q2 2025 Earnings Conference Call July 23, 2025 8:00 AM ET Company Participants Jonathan R. Monson - Executive VP & CFO Kenneth M.
Read More
Boston Scientific (BSX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Exploring Analyst Estimates for Boston Scientific (BSX) Q2 Earnings, Beyond Revenue and EPS
Published: July 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Boston Scientific (BSX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Read More
About Boston Scientific Corporation (BSX)
- IPO Date 1992-05-19
- Website https://www.bostonscientific.com
- Industry Medical - Devices
- CEO Michael F. Mahoney
- Employees 53000